## Glycogen Storage Disease Type IV (Andersen Disease) **Key Point:** GSD Type IV results from deficiency of the **branching enzyme** (α-1,4 → α-1,6 transglucosidase), leading to accumulation of **abnormal glycogen with short outer branches** and **progressive hepatic cirrhosis**. ### Enzyme Defect The branching enzyme normally transfers segments of outer chains (α-1,4 linkages) to create α-1,6 branch points. Without it: - Glycogen becomes increasingly insoluble and abnormal in structure - Accumulates as **polyglucosan** (abnormal, poorly branched polymer) - Triggers hepatocyte necrosis and inflammation - Leads to **cirrhosis** (unique among GSDs) ### Pathophysiology ```mermaid flowchart TD A[Branching enzyme deficiency]:::outcome --> B[Abnormal glycogen structure<br/>Short outer chains]:::outcome B --> C[Polyglucosan accumulation<br/>in hepatocytes]:::outcome C --> D[Hepatocyte necrosis<br/>& inflammation]:::action D --> E[Progressive cirrhosis<br/>Liver failure]:::urgent ``` ### Clinical Features - **Hepatomegaly** (early, moderate) - **Progressive cirrhosis** (unique among GSDs) — develops in infancy/early childhood - Failure to thrive - Ascites and splenomegaly (signs of portal hypertension) - Elevated transaminases (ALT/AST) - Hypoglycemia (mild, unlike Type I) - **Death from liver failure** by age 5 years (if untreated) ### Diagnosis - **Liver biopsy:** PAS-positive, diastase-resistant polyglucosan (pathognomonic) - **Enzyme assay:** branching enzyme activity in leukocytes or fibroblasts - **Genetic testing:** mutations in GBE1 gene **High-Yield:** GSD Type IV is the **only GSD that causes cirrhosis**. The abnormal glycogen structure (short branches, polyglucosan) is the key distinguishing feature. **Clinical Pearl:** Liver transplantation is the only definitive treatment and can halt disease progression if performed before irreversible cirrhosis develops.
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.